<- Go Home
Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Market Cap
DKK 141.5B
Volume
207.4K
Cash and Equivalents
DKK 726.0M
EBITDA
DKK 8.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
DKK 18.8B
Profit Margin
67.55%
52 Week High
DKK 959.00
52 Week Low
DKK 578.60
Dividend
3.50%
Price / Book Value
8.61
Price / Earnings
34.78
Price / Tangible Book Value
-10.51
Enterprise Value
DKK 165.0B
Enterprise Value / EBITDA
18.74
Operating Income
DKK 7.6B
Return on Equity
24.72%
Return on Assets
9.82
Cash and Short Term Investments
DKK 726.0M
Debt
DKK 24.2B
Equity
DKK 16.4B
Revenue
DKK 27.9B
Unlevered FCF
DKK 3.0B
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium